XML 42 R29.htm IDEA: XBRL DOCUMENT v3.22.1

SHARE-BASED PAYMENTS (Tables)

3 Months Ended

Mar. 31, 2022

Share-based Payment Arrangement [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of the stock options granted under the Compensation Plan for the three months ended March 31, 2022 was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions:

Risk-free interest rate			1.29		%
Expected life (in years)			3.25
Expected volatility(1)			72.24		%
Expected dividend yield			—		%
Weighted average grant date fair value			$	3.19

(1)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the stock options.

Schedule of Share-based Compensation, Stock Options, Activity

The summary of the Company’s stock options at March 31, 2022 and December 31, 2021, respectively, and the changes for the fiscal periods ending on those dates, are presented below:

			Range of Exercise Prices						Number of Shares						Weighted Average Exercise Price						Weighted Average Remaining Contractual Life (Years)						Intrinsic Value
Outstanding, December 31, 2020			$1.70 - $15.61						1,609,087						$	2.91
Granted			3.89 - 8.41						169,310						3.99
Exercised			1.70 - 7.42						(775,814)						2.95
Forfeited			1.76 - 5.91						(8,048)						3.16
Expired			1.70 - 15.61						(51,653)						8.14
Outstanding, December 31, 2021			$1.70 - $8.41						942,882						$	2.79
Granted			6.47 - 10.03						28,202						6.69
Exercised			1.70 - 5.18						(135,926)						2.41
Expired			2.35						(15,506)						2.35
Outstanding, March 31, 2022			$1.70 - $10.03						819,652						$	2.99					2.39						$	5,048
Exercisable, March 31, 2022			$1.70 - $7.14						745,822						$	2.79					2.20						$	4,746

The summary of the Company’s non-vested stock options at March 31, 2022 and December 31, 2021, respectively, and the changes for the fiscal periods ending on those dates, are presented below:

			Number of Shares						Weighted Average Grant Date Fair Value
Non-vested, December 31, 2020			403,990						$	0.94
Granted			169,310						2.06
Vested			(351,934)						1.23
Forfeited			(8,049)						1.60
Non-vested, December 31, 2021			213,317						$	1.34
Granted			28,202						3.19
Vested			(167,689)						1.12
Non-vested, March 31, 2022			73,830						$	2.53

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

The summary of the Company’s non-vested RSUs at March 31, 2022 and December 31, 2021, respectively, and the changes for the fiscal periods ending on those dates, are presented below:

			Number of Shares						Weighted Average Grant Date Fair Value
Non-vested, December 31, 2020			1,094,056						$	1.98
Granted			441,241						3.89
Vested			(635,233)						1.94
Non-vested, December 31, 2021			900,064						$	2.94
Granted			329,377						6.43
Vested			(518,856)						2.93
Non-vested, March 31, 2022			710,585						$	4.56

The summary of the Company’s SARs at March 31, 2022 and December 31, 2021, respectively, and the changes for the fiscal periods ending on those dates, are presented below:

			Number of Shares						Weighted Average Exercise Price						Weighted Average Remaining Contractual Life (Years)						Intrinsic Value
Outstanding, December 31, 2020			1,720,623						$	2.92
Exercised			(48,201)						2.92
Outstanding, December 31, 2021			1,672,422						$	2.92
Granted			730,686						6.47
Outstanding, March 31, 2022			2,403,108						4.00						2.73						$	12,377
Exercisable, March 31, 2022			1,098,873						$	2.92					1.81						$	6,846

The summary of the Company’s non-vested SARs at March 31, 2022 and December 31, 2021, respectively, and the changes for the fiscal periods ending on those dates, are presented below:

			Number of Shares						Weighted Average Grant Date Fair Value
Non-vested, December 31, 2020			1,720,623						$	1.25
Vested			(1,147,074)						1.27
Non-vested, December 31, 2021			573,549						$	1.19
Granted			730,686						3.60
Non-vested, March 31, 2022			1,304,235						$	2.54

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award

The components of share-based compensation are as follows:

									Three months ended March 31,
															2022						2021
Recognized expense
Stock options															$	32					$	200
RSU awards(1)															484						362
SARs															346						135
Total recognized expense															$	862					$	697

(1)The fair value of the RSUs granted under the Compensation Plan for the three months ended March 31, 2022 and 2021 was estimated at the date of grant, using the stated market price on the NYSE American.

Share-based Payment Arrangement, Restricted Stock Unit, Activity

The fair value of the SARs granted during the three months ended March 31, 2022 was estimated at the date of grant using a Monte Carlo simulation, with the following weighted average assumptions:

Risk-free interest rate			1.53		%
Expected life (in years)(1)			5.00
Expected volatility(2)			72.50		%
Expected dividend yield			—		%
Weighted average grant date fair value			$	3.60

(1)Monte Carlo analysis of SARs assumes employee suboptimal exercise at first vesting time for each tranche.

(2)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the stock options.

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of share-based payment arrangement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration